NewcelX partners with Eledon to develop diabetes treatment
Go back to NewcelX partners with Eledon to develop diabetes treatment| (NASDAQ: ELDN) | Delayed: 3.97 +0.05 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.92 | 52 Week High | $ | |||
| Open | $4.04 | 52 Week Low | $ | |||
| Day High | $4.49 | P/E | N/A | |||
| Day Low | $3.93 | EPS | $ | |||
| Volume | 3,696,414 | |||||
| (NASDAQ: NCEL) | Delayed: 3.50 +0.19 (5.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.31 | 52 Week High | $ | |||
| Open | $3.31 | 52 Week Low | $ | |||
| Day High | $3.59 | P/E | N/A | |||
| Day Low | $3.15 | EPS | $ | |||
| Volume | 29,868 | |||||
